Results 11 to 20 of about 280,167 (140)

Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda [PDF]

Contraception: X, 2019
Objectives: Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users.
Philip Anglewicz, Pierre Akilimali, Georges Guiella, Patrick Kayembe, Simon P.S. Kibira, Fredrick Makumbi, Amy Tsui, Scott Radloff   +7 more
doaj   +6 more sources

Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria [PDF]

Open Access Journal of Contraception
Adewole Adebola Adefalu,1 Olufunke Abimbola Bankole,2 Funmilayo Olabode,2 Mojuba Bimbo Afolabi,2 Miranda Atare Buba,2 Victor Dafe,2 Mishael Nnanna Kalu,2 Emily Watkins3 1JSI Research & Training Institute, Inc., Atlanta, GA, USA; 2JSI Research & ...
Adefalu AA, Bankole OA, Olabode F, Afolabi MB, Buba MA, Dafe V, Kalu MN, Watkins E   +7 more
doaj   +6 more sources

DMPA-SC self-injection experiences of clients and providers in Uganda: the role of community health workers in reproductive self-care service delivery [PDF]

BMC Women's Health
Accelerating task sharing for family planning and contraceptive self-care can minimize the impact of a projected shortage of 18 million health care workers by 2030.
Jane Cover, Allen Namagembe, Barbara Kunihira, Cecilia Nantume, Andrew Secor, Fiona Walugembe   +5 more
doaj   +5 more sources

Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study [PDF]

Reproductive Health
Background Depot Medroxyprogesterone Acetate (DMPA) in a prefilled auto-disabled subcutaneous injectable contraceptive (Uniject™) can be administered by community health workers and clients.
Aderaw Anteneh, Megan M. Lydon, Katherine M. Anfinson, Fikreselassie Getachew, Erica Felker-Kantor, Tihut Mulugeta, Teferi Teklu, Rahel Demissew, Holly M. Burke   +8 more
doaj   +4 more sources

Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results. [PDF]

Glob Health Sci Pract, 2019
Lay community health workers and facility-based health care providers in Benin were trained to administer DMPA-SC safely and effectively in 10 health zones.
Okegbe T, Affo J, Djihoun F, Zannou A, Hounyo O, Ahounou G, Bangbola KA, Harris N.   +7 more
europepmc   +6 more sources

Patterns of triggers, ideation and motivational factors of contraceptive utilization among women and gate-keepers in Nigeria: a scoping study on the resilient and accelerated scale up of DMPA-SC in Nigeria (RASUDIN) [PDF]

Contraception and Reproductive Medicine, 2020
Background Women have unfair share in the burden of unintended pregnancy outcome and unhealthy interpregnancy intervals. An understanding of the triggers, ideation and motivational factors influencing utilization of modern contraceptives is relevant for ...
Kehinde Osinowo, Michael Ekholuenetale, Oluwaseun Ojomo, Abiodun Hassan, Oladapo Alabi Ladipo   +4 more
doaj   +5 more sources

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries. [PDF]

Glob Health Sci Pract, 2018
Nearly half a million doses of DMPA-SC were administered over 2 years in Burkina Faso, Niger, Senegal, and Uganda, with 29% of doses provided to first-time family planning users and 44% (in 3 countries) to adolescent girls and young women under age 25 ...
Stout A, Wood S, Barigye G, Kaboré A, Siddo D, Ndione I.   +5 more
europepmc   +6 more sources

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]

Glob Health Sci Pract, 2018
Over 1 year, the NGO-led project provided more than 14,000 units of DMPA-SC, mostly in community settings and to a substantial proportion (43%) of young women.
Odwe G, Gray K, Kyarimpa A, Obare F, Nagendi G.   +4 more
europepmc   +6 more sources

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi. [PDF]

Glob Health Sci Pract, 2019
Community health workers can adequately provide DMPA-SC directly or train women on self-injection. Community health workers can adequately provide DMPA-SC directly or train women on self-injection.
Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Santo LD, Ngwira B.   +7 more
europepmc   +6 more sources

Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC). [PDF]

Eval Program Plann, 2018
In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016.
Stout A, Wood S, Namagembe A, Kaboré A, Siddo D, Ndione I.   +5 more
europepmc   +5 more sources